Author:
Shirai Junya,Kunisaki Chikara,Godai Ten-i,Watanabe Kazuteru,Oshima Takashi,Yukawa Norio,Fujii Shouichi,Rino Yasushi,Masuda Munetaka
Publisher
Japanese College of Surgeons
Subject
Cell Biology,Developmental Biology,Embryology,Anatomy
Reference18 articles.
1. 1) Whyte S, Pandor A, Stevenson M, et al:Bevacizumab in combination with fluoropyrimidine-based chemotherapy for the first-line treatment of metastatic colorectal cancer. Health Technol Assess 14:47-53, 2010
2. 3) Cassidy J, Clarke S, Díaz-Rubio E, et al:Randomized phase Ⅲ study of capecitabine plus oxaliplatin compared with fluorouracil/folinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancer. J Clin Oncol 26:2006-2012, 2008
3. 4) Sato A, Doi T, Boku N, et al:PhaseⅠ/Ⅱstudy of XELOX plus bevacizumab in Japanese patients with metastatic colorectal cancer (JO19380). (Article in Japanese) Gan To Kagaku Ryoho 38:561-569, 2011